OMER
Omeros CorporationNASDAQHealthcare$10.90-0.14%ClosedMarket Cap: $772.8M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-5.70
P/S
0.00
EV/EBITDA
-8.22
DCF Value
$-3.17
FCF Yield
-15.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
1.7%
ROA
-1.0%
ROIC
-45.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-29.1M | $86.5M | $1.42 | — |
| FY 2025 | $0.00 | NaN% | $-122.8M | $-3.4M | $-0.05 | — |
| Q3 2025 | $0.00 | NaN% | $-26.4M | $-30.9M | $-0.47 | — |
| Q2 2025 | $0.00 | -Infinity% | $-32.4M | $-25.4M | $-0.43 | — |
| Q1 2025 | $0.00 | NaN% | $-35.0M | $-33.5M | $-0.58 | — |
| Q4 2024 | $0.00 | -Infinity% | $-35.7M | $-31.4M | $-0.54 | — |
| FY 2024 | $0.00 | NaN% | $-169.3M | $-156.8M | $-2.70 | — |
| Q3 2024 | $0.00 | NaN% | $-35.4M | $-32.2M | $-0.56 | — |
| Q2 2024 | $0.00 | NaN% | $-59.2M | $-56.0M | $-0.97 | — |
| Q1 2024 | $0.00 | -Infinity% | $-39.0M | $-37.2M | $-0.63 | — |
| Q4 2023 | $0.00 | -Infinity% | $-39.8M | $-9.1M | $-0.15 | — |
| FY 2023 | $0.00 | NaN% | $-164.5M | $-117.8M | $-1.88 | — |